Amrize (NYSE:AMRZ) Given New $53.00 Price Target at UBS Group

Amrize (NYSE:AMRZ) had its price objective upped by UBS Group from $52.00 to $53.00 in a report issued on Monday,Benzinga reports. They currently have a neutral rating on the stock.

Other research analysts also recently issued research reports about the company. Wall Street Zen raised Amrize to a “hold” rating in a research note on Saturday, October 25th. JPMorgan Chase & Co. boosted their target price on Amrize from $52.00 to $60.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 26th. Barclays started coverage on Amrize in a research note on Tuesday, October 7th. They set an “equal weight” rating for the company. Oddo Bhf started coverage on Amrize in a research note on Monday. They set a “neutral” rating for the company. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Amrize in a research note on Thursday, October 30th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $58.71.

Amrize Stock Down 1.4%

AMRZ stock opened at $51.11 on Monday. The firm has a market capitalization of $28.27 billion and a P/E ratio of 65.52. The company has a 50-day moving average of $50.61. Amrize has a 52 week low of $44.12 and a 52 week high of $56.29. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.85 and a current ratio of 1.38.

Amrize (NYSE:AMRZ) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.78 EPS for the quarter, missing analysts’ consensus estimates of $1.03 by ($0.25). The company had revenue of $3.22 billion during the quarter.

Insider Buying and Selling

In other news, insider Mario Gross bought 3,000 shares of the firm’s stock in a transaction on Wednesday, August 13th. The stock was acquired at an average price of $49.63 per share, with a total value of $148,890.00. Following the transaction, the insider owned 23,232 shares of the company’s stock, valued at $1,153,004.16. This trade represents a 14.83% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Stephen S. Clark bought 5,000 shares of the firm’s stock in a transaction on Friday, August 15th. The shares were purchased at an average cost of $51.82 per share, with a total value of $259,100.00. Following the transaction, the insider directly owned 5,000 shares in the company, valued at approximately $259,100. This trade represents a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 1,179,000 shares of company stock valued at $56,120,460 over the last three months.

Institutional Trading of Amrize

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. TD Asset Management Inc acquired a new stake in Amrize during the 2nd quarter valued at approximately $8,190,000. Allianz Asset Management GmbH bought a new position in shares of Amrize during the 2nd quarter worth approximately $158,530,000. Allspring Global Investments Holdings LLC bought a new position in shares of Amrize during the 2nd quarter worth approximately $62,646,000. Bessemer Group Inc. bought a new position in shares of Amrize during the 2nd quarter worth approximately $16,489,000. Finally, Rockbridge Capital Management LLC bought a new position in shares of Amrize during the 2nd quarter worth approximately $1,996,000.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.